Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen.
about
An example of nonrandom missing data for hepatitis C virus status in a prognostic study among HIV-infected patients.CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa.Antiretroviral therapy in the clinicCumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDSIs long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysisFactors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected womenHIV RNA suppression and immune restoration: can we do better?Assessment of the impact of adherence and other predictors during HAART on various CD4 cell responses in resource-limited settings.Poor follow-up rates at a self-pay northern Indian tertiary AIDS clinic.Immune reconstitution disease associated with parasitic infections following antiretroviral treatment.Pregnancy may be followed by an inflexion of the immune reconstitution in HIV-infected women who receive antiretroviral drugs before conception.Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD)Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.HIV protease inhibitors: recent clinical trials and recommendations on use.Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study.Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switch.Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study.Prognostic value of changes in CD4 count and HIV RNA during the first six months on highly active antiretroviral therapy in chronic human immunodeficiency virus infection.Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs.Long-term outcome of HIV-infected patients with multinucleoside-resistant genotypes.Information that should be given to HIV cohort participants during ongoing research: the viewpoints of patient representatives and research professionalsBivariate Longitudinal Model For The Analysis Of The Evolution Of Hiv Rna And Cd4 Cell Count In Hiv Infection Taking Into Account Left Censoring Of Hiv Rna Measures
P2860
Q33207755-44E32702-25CA-4F40-B776-1E784F2C0A9EQ33237178-442376B6-A0A5-45B2-B41F-7A54BA65B99CQ33877347-E66D7948-A8F7-478F-B1AD-A299F53DB0D0Q33916321-0A20BF55-4A71-49A5-87AF-760A4DD886FAQ34079293-C9B0D813-88A5-47D5-BFAE-2C50DF777953Q34518299-7B33E9BC-AE50-4F6F-ACAE-A8C00AFE65F4Q35077997-FFF526C3-2C27-4CA8-B88B-1A571E0694B6Q35867173-D05CB30C-E156-4F96-A3D1-4A029E0CCA5CQ35905907-7428E52C-BD13-4FF5-B98C-1EADD5A6381BQ36384061-FD1FFB07-3EA5-46AE-922B-25F6BB25F330Q36624200-95B79477-CDFD-42D3-9EE9-A8C11BFCDD15Q37340000-90ED8A2F-9B7A-4AE2-B062-D35260A4E1EDQ37364321-AFC4DCD6-2B72-4523-A682-5BC1C3965153Q37477423-053F6C97-D610-45F3-A1E9-739BCF14AB4FQ37519715-6DD4B422-82E5-4E63-A3CC-A27218880E34Q38917930-9D017498-B2A0-4F00-A35F-F1C0B420A63FQ39006642-4AAB3F73-0755-43D0-880F-3AE8AE7951AFQ39528150-10D5CFEC-1836-4AE1-979E-7BC5C3129982Q44256226-6F3D81F6-281A-4F2D-8CC2-869082DD51A1Q44363076-68206AA2-276D-4110-A446-92D4A272591FQ44566864-88C13FE0-39ED-4AA7-ACED-E8B4F33AA146Q53911156-0C7E7C2A-0BB6-4925-9B9C-9BB1D3FF02E3Q56775915-8DB77400-F06B-4094-A0D2-84E354D6BEFCQ56837872-B905F0AE-F3B9-421E-B5CB-C11A1E2FFBE1
P2860
Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Predictors of long-term increase in CD4
@nl
Predictors of long-term increa ...... aining antiretroviral regimen.
@en
type
label
Predictors of long-term increase in CD4
@nl
Predictors of long-term increa ...... aining antiretroviral regimen.
@en
prefLabel
Predictors of long-term increase in CD4
@nl
Predictors of long-term increa ...... aining antiretroviral regimen.
@en
P2093
P50
P356
P1476
Predictors of long-term increa ...... aining antiretroviral regimen.
@en
P2093
APROCO Study Group
Catherine Leport
Christian Michelet
François Raffi
Hervé Fleury
Serge Herson
Valérie Cailleton
P304
P356
10.1086/338929
P407
P577
2002-01-31T00:00:00Z